In support of the national Cancer Moonshot initiative, this program seeks to leverage intellectual property assets held by the USPTO to accelerate cancer research and development. By providing free access to patented technologies related to cancer treatment or diagnosis, it aims to facilitate collaborations among researchers, startups, and pharmaceutical companies working towards finding effective cancer therapies.